13 1 Iodine (13 1 1) labelled antibody directed against human chorionic gonadatrophin (hCG) was given on 21 occasions to 18 patients with hCG-producing neoplasms. Tumours were localized by external scintigraphy in 13 of 21 investigations. Positive results were obtained reliably when serum hCG exceeded 500 miu/ml and in some cases sensitivity was comparable to that of computerized tomography. A positive result probably implies viability in the tumour and this was of practical value in discriminating between necrotic deposits and living tumour before surgery.
Introduction
Human chorionic gonadotrophin (hCG) is produced almost invariably by choriocarcinoma and hydatidiform mole, frequently by malignant teratoma and occasionally by a wide range of other tumours. It is present on the cell membrane, is normally released into the circulation and has proved a clinically useful serum tumour marker (see Bagshawe & Searle 1977) . It would be of further value if deposits of these tumours could be localized by virtue of their hCG production.
Localization of carcinoembryonic antigen (CEA) producing tumours in man has already been achieved by external scintigraphy after injection of radiolabelled antibody directed against CEA. This followed the demonstration that antibody to CEA was specifically concentrated in CEA-producing xenografts of human colonic tumours in experimental animals (Mach et al. 1974 , Primus et al. 1977 .
This paper describes the localization of deposits of hCG-producing tumours by external scintigraphy after injection of radiolabelled antibody directed against hCG (anti-hCG) . Methods 
Gammaglobulin preparations
Antisera to intact hCG were raised in a sheep (124) and a rabbit (JB12). The anti-hCG gammaglobulins (5 mg) were eluted by ammonium thiocyanate (2.5 mol/l in phosphate (0.05 mol/l, pH 7.5) after passage of the decomplemented serum (25 ml) through a column of immoblized hCG (2.6 cm diameter x 25 cm height; hCG linked to CN-Br-activated Sepharose 4B (Pharmacia), surmounting Sephadex G-25, 44 cm, for desalting).
Labelling procedure
Gammaglobulins (500 jg), previously checked for non-pyrogenicity in rabbits, were iodinated at 0°C with 1311I(2.5 mCi Radiochemical Centre, Amersham eluted (6 ml) from autoclaved Sephadex G-200 (2 cm diameter x 15 cm height, equilibrated in phosphate buffer 0.105 mol/l, pH 7.5), the first 1 ml fraction of iodinated protein, which contained aggregated IgG, being discarded. The immunological activity of the antibody for 125Iodine-labelled hCG was checked before and after labelling; 50-70% was retained. The affinity of JB 12 is such that 100 RI of a solution of 450 miu/ml of hCG displaces 50% of tracer '251-hCG bound by 50,l of a 2,g/ml solution of the gammaglobulins in double antibody radioimmunoassay.
Administration of the labelled antibody (anti-hCG) and imaging procedure Patients received potassium iodide 60 mg three times daily for 10 days, beginning 24 hours before administration of the antibody. Provided that intradermal injection of 1,g of the antibody produced no reaction, the labelled antibody preparation (12 ml) in 0.9% saline was given intravenously over 1-2 min. Four-hourly temperature, pulse and blood pressure were taken on the day of administration. Scans were obtained at 24 hours after injecting anti-hCG. Background radioactivity distribution was assessed with the aid of a second radioactive marker. 99mTechnetium (99mTc) as sodium pertechnetate (Tc04) (Radiochemical Centre, Amersham) and 500 ,uCi of 99mTc labelled human serum albumin (99mTc-albumin) (TCK-Z, CIS(UK)) were injected intravenously. In 6 patients 99mTc-labelled red cells were used for background identification instead of 99mTc-albumin and 99mTcO4. This was achieved in vivo by the consecutive intravenous injection of the non-radioactive bone scanning agent stannouschloride EHDP followed 10 min later by 99mTc sodium pertechnetate. A Nuclear Enterprises LFOV gamma-camera coupled to a Varian Nuclear Medicine computer was used to obtain displays of 131Iodine localization, 99mTc localization and subtracted scans, for anterior, posterior and lateral views (after Goldenberg et al. 1978) . Images of the distribution of radioiodine and technetium were inspected on a television display but were rarely helpful by themselves. Successive amounts of radioactivity corresponding to the technetium distribution were subtracted from the radioiodine scan, until the images ofcertain appropriate recognizable structures, particularly the heart, vascular tree, or stomach, had been eliminated. Remaining distributions of radioiodine at this stage were regarded as potential sites of malignant disease, especially if present on more than one view.
Separation of immune complexes
Serum (3 ml) was applied to a column of Sephacryl S-200 superfine (Pharmacia, 2.6 x 100 cm) equilibrated with Dulbecco complete PBS. The column was eluted at a flow rate of 50 ml/hour and 2 ml fractions were collected. The optical density at 280 nm was measured spectrophotometrically (Uvicord, LKB) and the level of 1311 in the fractions was determined using a Wallac Model 80 000 gamma sample counter.
Assay for hCG
Concentrations of the beta subunit of hCG were measured by the method of Kardana & Bagshawe (1976) .
Results
Eighteen patients were studied, 3 having repeat investigations during the course of their treatment; 0.30-1.44 mCi of anti-hCG was administered with a specific activity of 0.6-2.0 mCi/mg of protein. Fever up to 37.5°C was recorded in 2 patients during the 12 hours after injection of antibody but no other adverse effect was detected.
The results of scanning are summarized in Table 1 . Thirteen of the total of 21 studies were unequivocally positive in one or more area. The sites identified corresponded with sites of involvement indicated by conventional radiology, with the exception of a cerebral deposit of malignant teratoma which was clearly shown by computerized tomography (CT) but not detected by radioimmunolocalization (RIL). Deposits were most readily demonstrated when the bulk of tumour was large as shown by serum hCG concentration above 500 miu/ml. Below this level equivocal or negative results were often obtained. The presence of tumour was The isotope is concentrated principally in the heart and stomach (see Discussion). (D) Image produced by computer subtraction of c from B. The increased uptake in the left lower zone suggests the presence of two deposits of choriocarcinoma (arrowed) confirmed by surgery in 4 patients. In one (Figure 1 ) there were 2 deposits in the left lower lobe, corresponding better with RIL that with CT. In 2 patients (10 and 13 in Table 1 ) microscopic areas of choriocarcinoma .were demonstrated at the site of equivocal antibody retention. Two patients (15 and 18 in Table 1 ) with lung metastases and elevated serum hCG at the start of treatment had negative RIL after serum hCG had become undetectable.
Opacities were still seen in the lungs by conventional radiology at this stage. In one patient the deposits were excised and found to contain only differentiated teratoma with no trophoblastic or other elements likely to produce hCG. In the other the opacities were presumed to represent either necrotic tissue or non-hCG-producing elements of the tumour. Examples of 2 patients (9A and 6 in Table 1 ) with positive scans are shown in Figures 1 and 2 . The tendency of the radiolabclled antibody to form aggregates or immune complexes with hCG in the circulation was studied by gel filtration ofserum samples. The 31' immunoglobulin injected was largely in a monomeric form as shown in the upper part of Figure 3 . However, within 75 minutes of injection the majority had moved into the lower numbered fractions, which contain higher molecular weight material, suggesting that the majority of antibody had complexed with circulating hCG (Figure 3, lower) . This pattern was maintained up to the time of scanning (24 h) although elements with the very highest molecular weight (first peak) appeared to have been cleared. Table 1 ). (A) Pelvic ultrasound showing a large tumour in the region of the right ovary. (B) 1311 gamma-camera image of posterior abdomen after administration of 131 I anti-hCG. This isotope is concentrated principally in the bladder, major blood vessels and right side of the pelvis. (c) 99mTc gamma-camera image of posterior abdomen. This isotope is concentrated principally in the bladder and major vessels. (D) Image produced by computer subtraction of c from B. Increased uptake in the right side of the pelvis suggests the presence of a deposit of choriocarcinoma Discussion RIL of deposits of choriocarcinoma and malignant teratoma by virtue of their production of hCG differs from conventional imaging techniques in that it appears to depend on a specific property of viable tumour. This assertion is based on studies in our department with nude mice bearing xenografts of a human choriocarcinoma. Five days after intravenous injection, twice as much anti-hCG as normal gammaglobulin was retained in the tumours, whereas the antibodies were present in equal quantities in normal tissues (J C M Lewis, unpublished data). Similar results have been obtained using antibody directed against CEA in CEA-producing xenografts (Mach et al. 1974 , Primus et al. 1977 , Searle et al. 1980 and patients with carcinoma of the rectum (Mach et al. 1980 ). The localization of hCG-producing tumours presented here is similarly presumed to depend on specific retention of antibody, although the mechanisms are not yet adequately defined in man. Even though antibody may concentrate in the tumour in ideal circumstances, if the serum concentration of hCG is high it might be expected that almost all the anti-hCG would form circulating immune complexes with hCG, leaving little or no antibody free to bind to the tumour. The circulating immune complexes might be cleared by tissue-bound macrophages, particularly those in the liver and give a false impression of tumour localization in that organ. Alternatively, if they persisted in the circulation any tumour uptake might be obscured by high blood background.
In practice, excess uptake of anti-hCG by the liver was unusual. However, most of the antibody administered did appear to remain in the circulation and judging from the two patients whose sera was studied by gel filtration, most was in complexed form. This did not prevent successful localization of tumours even in patients with serum beta-hCG as high as 200 000 miu/ml. The existence of an equilibrium between reaction of anti-hCG with tumourbound hCG and with that in extracellular spaces could explain this finding. The fact that the gamma-camera pictures of the distribution of 13 1I-labelled antibody were principally images of the circulation gives an indication of the small proportion of anti-hCG which binds to tumour and illustrates the need for the subtraction procedure if the tumour deposits are to be identified.
The use of technetium to identify nonspecific background radiation in the patient is far from ideal. The gamma-camera responds to the lower energy gamma rays of technetium by producing images which are ofslightly different size and position from those pictures produced with high energy radioiodine. Considerable effort has to be made to adjust the camera in order for the images to be directly comparable. The mixture of technetium albumin and sodium pertechnetate is used to mimic the nonspecific distribution of radioiodine which is partly in the vascular compartment and partly extravascular, some of it being free iodide from degraded anti-hCG. Though pertechnetate and iodide are handled very similarly in the body, the background image can only be an approximation and because of this there remains a subjective element in the interpretation of the images. This is particularly so in the region of the bladder and of the stomach where technetium uptake, though providing valuable anatomical localization, may be obviously disproportionately great. The technique was varied in 6 patients using a predominantly blood pool marker (technetium-labelled red cells) but our impression was that this merely produced distortions in a different direction. The body blood pool was disproportionately well displayed compared with the distribution of radioiodine. At present our impression is that the mixture of technetium albumin and sodium pertechnetate as recommended by Goldenberg et al. (1978) is probably more satisfactory. The method gave results comparable to those of computerized tomography in terms of the size of lesions identified. It has the substantial advantage that identification of a deposit by virtue of one of its products probably implies viability and gives an indication of the type of tissue from which the tumour derives. This property may be of practical value in patients with drug-resistant choriocarcinoma and malignant teratoma, where elevated serum hCG indicates the presence of as little as 104-105 cells. If the site of tumour can be identified, surgical excision may contribute to cure. Indeed, all 4 of the patients in this study in whom choriocarcinoma was resected from the lung appear to have benefitted, although it is too early to say whether their tumours have been eradicated. Abnormalities in the lung field were also shown by CT in each patient and whilst these were likely to be caused by viable tumour, similar appearances can be produced by necrotic choriocarcinoma or by differentiated or necrotic teratoma (Newlands et al. 1980) .
The sensitivity of the method is difficult to define accurately at this early stage. Apparently tumours as small as 1-2 cm diameter and producing serum hCG in the region of 500-1000 miu/ml can be localized reliably, though the equivocal results achieved below this level raise the possibility that greater sensitivity will be achieved with more experience in interpretation.
Direct comparisons with sensitivity of RIL of CEA-producing tumours cannot yet be made. Compared with our own and published work (Goldenberg et al. 1978 , Dykes et al. 1980 , Searle et al. 1980 , Mach et al. 1980 , our subjective impression is that anti-hCG RIL has at least as great potential as a useful clinical tool as anti-CEA RIL.
The results are preliminary but show the promise of the method as a clinical tool and justify further investigation of the sensitivity and applications of RIL with hCG-producing neoplasms. The findings also encourage the exploration of new immunological and imaging techniques which may improve sensitivity and specificity and allow RIL with a wider range of marker producing tumours.
